Dutch initiative for more reliable, easier-to-find information on medicines

3 December 2018

Patients need reliable and comprehensible information on medicines that is easier to find online. In order to achieve this, Bruno Bruins, Minister of Health, Welfare and Sport in the Netherlands, has launched the Network Patient Information.

Seven organizations have signed a letter of intent and will be working together on achieving this goal. The first specific step to be taken will be to link four different websites: the Netherlands Medicines Authority (MEB), the Netherlands Pharmacovigilance Center (Lareb), the GPs (NHG, Thuisarts.nl) and the pharmacists (KNMP, Apotheek.nl).

The Research Institute NIVEL, the Dutch Center of Expertise on Health Disparities Pharos, and the Patients Federation Netherlands will all advise the participants in the Network. With their relevant knowledge, the Network can take into account the requirements and preferences of people who use medicines in the Netherlands.

This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Try before you buy

Free

7 day trial access

Take a Free Trial

All the news that moves the needle in pharma and biotech
Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
Receive The Pharma Letter daily news bulletin, free forever.

Become a subscriber

£820

Or £77 per month

Subscribe Now

Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
Daily roundup of key events in pharma and biotech.
Monthly in-depth briefings on Boardroom appointments and M&A news.
Choose from a cost-effective annual package or a flexible monthly subscription

The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK